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INTRODUCTION
Major cardiothoracic surgery is associated with release of local and systemic mediators, acting on vascular and pulmonary systems which may be compromised by underlying disease [1] . Although improvements in survival and infection rates have been reported following minimally invasive surgery, the underlying mechanisms remain poorly defined. Following surgery, there have been reports of improved outcomes of minimally invasive techniques on immunosuppression, measured as infection rates, circulating lymphocytes and immunoglobulins [2] [3] [4] [5] [6] . Circulating immunoglobulins play an important part in immunity and immunoglobulin preparations have been used for prophylaxis for patients at high risk from sepsis [7, 8] . However, there has been little analysis of whether differences in post surgical immunoglobulins are due to changes in immunoglobulin turnover or blood loss. Also, prospective randomised trials of minimally invasive surgery have become more difficult to perform, as the use of conventional open surgery has decreased and minimally invasive approaches have become the method of choice. In the current randomised prospective study of minimally invasive pulmonary lobectomy, humoral opsonins, including immunoglobulins, complement, selectins and TNF binding proteins were analysed, to determine immunological and humoral biomarkers following surgery.
It is well known that the cytokine network is closely linked to inflammatory and vascular signals, and emerging evidence suggest that it undergoes specific changes following minimally invasive surgery.
IL-6 is a characteristic marker of minimally invasive surgery. IL-6 levels increased by up to 18-fold within two days of major surgery [9] . We previously detected lower IL-6 release in VATS, compared with conventional open surgery in the patient group used in this study following pulmonary surgery [10] . Characteristic IL-6 changes were also detected in other sites of minimally invasive surgery. In a study of laparoscopic excisions for rectal cancer, IL-6 decreased 1 and 5 days after laparoscopic surgery, but increased after open surgery, but not TNF [11] . In the patient group covered by this study we also reported that TNF was unchanged, and in this paper we describe post surgical changes in circulating TNF binding proteins which may neutralise locally released TNF. We also report post surgical changes in opsonins that link humoral mediators including IL-6 and lung tissue immunity:
selectins and complement. The selectins link stress signals, including NF-B and ATF-2 factors, to vascular responses. P-, E-, and L-selectin recognize leukocyte and endothelial glycoproteins and Pselectin is elevated in patients with haemolytic disease and lung cancer [12] [13] [14] . Complement and selectins also act as acute phase mediators [14] . Complement serum proteins, especially C3 and C4, may be produced by a wide variety of tissues and circulating immune cells such as macrophages, although the greatest amount originates from the liver [15] . C3 and C4, especially, are associated with elevated IL-6, which stimulates renal acute phase protein production [16] . Elevated haemolytic complement activity (CH50), a biomarker of haemolytic complement in the classical pathway, is associated with cancer, infection and conditions associated with chronic inflammation [15] . Therefore, in this study, the role of these circulating opsonins in linking immunological and vascular responses (CH50 and P-selectin) were investigated.
The immunoglobulins are major humoral mediators, playing a central role in immune surveillance and also a local role in lung pathophysiology. This study investigates the impact of pulmonary surgery on circulating immunoglobulins. The lung is a site of specific anaphylactic responses and of immunosurveillance. In the patient group used in this study, we previously reported differential changes in immunoglobulin producing B cells and T cells controlling the immune response following minimally invasive surgery [3] . Additionally, oxygen tension in pulmonary tissue is high, and changes in oxidative metabolism were detected in circulating leukocytes, which differed in VATS patients [3, 10] . However, while there have been recent advances in understanding ROS bioactivity at a cellular level, less is known about their activity in integrated whole body network responses. In the current study, changes in immunoglobulins, complement, selectins and TNF binding proteins were analysed in individual patients. These changes were compared with previously identified cellular and humoral biomarkers (ROS and acute phase mediators), to investigate potential network and mediator interactions during the post-operative period.
MATERIALS AND METHODS
In this communication, we present previously unpublished data obtained from a prospective randomised trial, analysing peripheral venous blood samples collected during a study of acute phase [10] and leukocyte [3] changes following minimally invasive or conventional surgery for brochogenic carcinoma. The numbers of patients in each group was calculated from previous reports of leukocyte changes after surgery [3] derived from post surgical leucocyte ranges reported in laparoscopic surgery trials, and patient inclusion criteria have been described [3, 10] . To summarize, patients with peripheral pulmonary opacity consistent with peripheral brochogenic carcinoma underwent standard surgical assessment and staging by bronchoscopy, mediastinoscopy and computed axial tomography of thorax and upper abdomen. Routine haematological and biochemical analysis (Haemoglobin, urea) and blood loss analysis was performed to monitor haemodilution following surgery. Local ethical committee permission was obtained, and patients scheduled to undergo pulmonary lobectomy were randomly Laser nephelometry was used to measure IgG, IgM, IgA, C3, C4 [17, 18] . Haemolytic activity of complement (CH50), used haemolysis of sheep erythrocytes sensitized by C3, C4 specific antibodies (One CH50 unit: volume of serum lysing 50% erythrocytes). P-selectin TNFR-I and -II were analysed using monoclonal antibodies supplied by British Biotechnology, London UK and Monosan, Brussels, Belgium, respectively based ELISA, as described previously [10] . The change in opsonins and mediators after surgery was calculated as percent of pre-surgical levels within each patient. Results are expressed as median or mean + SEM. Results significantly different from pre-surgical levels were analysed using the Wilcoxon matched pairs signed two tailed rank test, comparing pre-operative and post-operative opsonin levels within the same patient. Significantly different results were dentoted * p<0.05, ** p<0.005 and *** p<0.0005. The correlation between changes in related parameters after surgery was analysed using simple linear regression analysis. Patients with malignant histology predominated in both open and VATS study groups. There were 18 patients with malignancy in the open surgery group and 18 patients with malignant histology in the VATS group. 
RESULTS

Changes in Immunoglobulins following Surgery
Substantial decreases in venous IgG, IgM and IgA were detected after surgery in patients undergoing pulmonary lobectomy (Table 1 ). In pre-operative patients, a relatively wide range of immunoglobulin levels were detected, which overlapped with postoperative immunoglobulin levels (Fig 1) and therefore post-operative changes in individual patients were analysed, as these changes were the focus of this study. IgG, IgM, IgA decreases (+SEM) were: IgG 21+3%(18+2%), IgM 13+3%(6+10%), IgA decreased by 18+4% (12+2%) in open and (VATS) patients 48 hours after surgery, and decreased 13+3%(12+3%) IgG, was detected one week post-operatively (Fig 2A) . IgM also significantly decreased one week postoperatively in open surgery patients, but not in VATS patients (Fig 2B) . IgG, IgM and IgA were significantly different from pre-operative immunoglobulins, 2 days after surgery.
Postoperative changes in IgM reached greater significance in open surgery patients. Samples were taken pre-operatively (0) and 2 and 7 days after surgery. Evidence for an effect of minimally invasive surgery on immunoglobulin production in the patient group used in this study included a substantial decrease in lymphocytes following surgery [3] . The kinetics of immunoglobulin (Fig 2) and lymphocyte decreases were similar: both circulating immunoglobulins and lymphocyte numbers decreased two days after surgery. Immunoglobulin decreases were more significant in patients undergoing open surgery (Table 1 and Fig 2) . Decreases in immunoglobulin producing cells and T cells were previously reported in this patient group (B cell numbers decreased by 22% in open surgery, and 18% in VATS patients two days after surgery), and even greater decreases were observed in CD4 T helper cells (32% after open surgery, 22% in VATS) [3] .
Complement and TNF Receptor Release following Surgery
Pulmonary surgery was associated with increased complement release, detected as circulating C3 and C4 one week after surgery (Table 1, Fig 3A) . C3 and C4 increased 29+9% 7 days after surgery (P<0.005, paired t-test, comparing pre-and post-surgical C3, C4 within same patient). There was evidence of reduced C4 release in VATS (31+11% open surgery; compared with 22+6% in VATS patients). The complement increase occurred later than immunoglobulin changes, which were significantly greater on day 2 after surgery (Fig 2) , and there was evidence of reduced C4 release in VATS patients (Fig 3A) . Increased post-operative C3 and C4 in VATS and open surgery could indicate a slow onset "acute-phase" response. This response may be partially inflammatory, as complement haemolytic index of activation (CH50) indicated end-activation of complement at day 7 in open surgery, but not in VATS patients (Table 1 ). Proteolytic cleavage of C3 or C4 during complement activation depletes serum C3 and C4. The high correlation between C3 and C4 changes indicated a possible common clearance pathway in thoracotomy patients. In this preliminary study of inflammatory and endothelial biomarker changes, we detected gradual increases 2-7 days after thoracotomy (Table 2 ). In this small study group, no significant early changes in these markers were detected in the immediate post surgical period, in samples taken 4h after surgery, but changes were detected at 2-7 days after surgery. Soluble human TNFR type I/II increased after surgery and similar TNFR-I increases were detected in both surgical groups. However, increased
TNFR-II (linked to immunomodulation) was detected in open thoracotomy (but not VATS) patients
48h and 120h post-op (Fig 3B) . Pre-operative TNFR-II levels in our study fell within the normal range, 121+ 84 ng/ml. It was also observed that P-selectin decreased 24-48h post-op in VATS patients, whereas a gradual increase (of up to 60%), was detected in open surgery patients [12, 14] . Results significantly different from pre-operative values (day 0), *p<0.05; **p<0.005; ***, p<0.0005.
DISCUSSION
The period immediately following surgery is important for survival. Acute phase and local mediators of surgical trauma influence immunity, vascular and pulmonary function [10, 11] . These mediators are involved in the response to infection and longer term processes, including metastatic growth [19] .
While minimally invasive surgery is associated with improved morbidity and mortality [2] , the underlying mechanisms are complex and involve humoral and cellular networks of the immune and vascular sytem [20] . The aim of this study was to analyse post-surgical immunoglobulins, complement and other opsonins, to find whether minimally invasive surgery affected these mediators, and to relate these changes to other biomarkers of immune function and surgical trauma. Changes in opsonins and inflammatory/endothelial biomarkers were analysed within individual patients in a randomised prospective study of 41 patients undergoing pulmonary lobectomy. Substantial changes in opsonins were detected after surgery, but differences between surgical groups were small, suggesting that minimally invasive surgery had less impact on opsonisation than on acute phase changes in these patients.
Immunoglobulins play an important part in immunity. Venous IgG, IgM and IgA decreased substantially following surgery (Table 2 ). Both circulating immunoglobulin (Fig 2) and lymphocyte numbers [3] decreased two days after surgery, and immunoglobulin decreases were more significant in patients undergoing open surgery (Fig 2) . These immunoglobulin decreases were greater than the haemodilution observed in these patients (Table 1) , and immunoglobulin differences between surgical groups were also greater than haemodilution differences. We previously reported decreases in immunoglobulin producing B cells and T cells in the patient group used in this study and also differences between lymphocyte counts in open and minimally invasive patients [3] . A similar pattern of immunoglobulin and lymphocyte changes were detected following laporoscopic cholecytstectomy, with lymphocyte changes that were greater than blood immunoglobulin changes [21] . Also, we observed that lymphocyte ROS, which influence lymphocyte proliferation and apoptosis [22] , were lower in VATS patients [3, 4, 20] Complement (C3 and C4) 7 days after surgery. Less negative correlations between C3 and C4 and phagocyte ROS were detected in VATS patients indicating higher connectivity between opsonins and immune signalling after minimally invasive surgery. Pulmonary surgery was associated with increases in circulating complement C3 and C4, one week after surgery (Table 1) . But this change was more gradual than immunoglobulin changes (Fig 2) and acute phase reactants [10] , and C4 release was slightly reduced in VATS patients (Fig 2A) . Increased C3 and C4 following surgery could indicate a slow onset "acute-phase" response. C3 and C4 may also represent a renal response to IL-6 released as a result of trauma, particularly muscle damage [23, 24] which is lower in minimally invasive procedures.
Also, in a small preliminary study of circulating inflammatory and endothelial biomarker in part of the study group, increases in TNF receptor were observed (Table 2) , which were smaller and slower than the rise in IL-6 levels (which peaked in these patients 4-12h after surgery). The kinetics of TNFR-II increases ( Fig 3B) resembled C4 changes ( Fig 3A) and these may be part of homeostatic responses to inflammatory stimuli elicited by surgery. Elevated circulating TNFR-II also correlates with progression of systemic inflammatory responses to sepsis and mortality [25] . A cellular target associated with metastatic progression is P-selectin [19] , and the gradual TNFR-II increase we observed indicated 
